Info
Asset
|
1h
|
24h
|
7d
|
1m
|
1y
|
max
|
|---|---|---|---|---|---|---|
nome
| - | - | - | - | - | - |
Genome Protocol Price Statistics
Market Cap Rank
#17542
Market Cap
-
Circulating Supply
-
Total Supply
-
Max Supply
-
Fully Diluted Valuation
-
24 Hour Trading Vol
-
24h Low / 24h High
0/0
All-Time High
0%
11 April, 2026, (a few seconds ago)
All-Time Low
0%
11 April, 2026, (a few seconds ago)
Genome Protocol Performance
Trading Pair
day
week
month
nome
/
usd
0%
0%
0%
nome
/
btc
0%
0%
0%
nome
/
eth
0%
0%
0%
About Coin
Web3 is growing rapidly, but it lacks the infrastructure to understand, grow, and retain new and existing users. Many studios face the challenge of turning attention into meaningful, measureable, and retainable growth.
Genome solves these problems by turning engagement into programmable, lasting value. Our approach adapts to user behavior in real time, rewarding high value actions and creating persistent value flows between platforms and people.
We're creating the foundation for InfoFi, an intelligent, scalable infrastructure in a single programmable layer that captures, scores, and rewards real user behavior across any platform.
This foundation powers persistent, engagement across all chains, apps, games, protocols, and campaigns. It transforms how you attract and retain users, and measure value.
IMPORTANT DISCLAIMER:
The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.